3rd Quarter - Report

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION

Firm
Client
Income
—
Expenses
$710,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Drug Shortages; The Preserving Access to Life Saving Medicines Act (S. 296)

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON —
PAUL ROMNESS —
ALANNA PORTER TEMME —

Contacted: SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Bills named: S. 296 (112th)

Copyright/Patent/Trademark CPT

Patent Settlements

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON —
PAUL ROMNESS —
ALANNA PORTER TEMME —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA)

Health Issues HCR

Health Care Reform; Pricing/Rebates; Importation; Coverage; Independent Patient Advisory Board

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON —
PAUL ROMNESS —
ALANNA PORTER TEMME —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

Rebates for Dual Eligibles and Low Income Subsidy Populations in Medicare Part D; Fiscal Cliff

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
JONATHAN REA MCPHERSON —
ALANNA PORTER TEMME —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Animals ANI

Illegal Compounding

LobbyistCovered position, as disclosed
AMY CHEVALIER EFANTIS —
ALANNA PORTER TEMME —

Contacted: SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.